( )
doi: 10.1056/NEJMoa2024816 Summary Keywords advances, kidney disease, pathogenesis, therapy, APOL1 gene Citation Boima V, Agyekum AB, Ganatra K, Agyekum F, Kwakyi E, Inusah J, Ametefe EN and Adu D (2025) Advances in kidney disease: pathogenesis and therapeutic targets
That level of evidence places Motus well ahead of stimulant-only supplements like Zantrex Black when you compare product-level human trials
Although there have been significant studies conducted on the pathophysiology and etiology of hypertension, it is still the case that over 95% of individuals with hypertension do not have a known cause
FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation
Sample Timing We generally recommend a 9am sample for thyroid testing